Business ❯Pharmaceutical Industry

Drug Manufacturing

Supply Chain Issues Novo Nordisk Pricing Strategies Supply Chain Management Legal Issues Market Competition Compounding Pharmacies Generic Drugs Compounding Facilities Illegal Operations Pain Relief Medications Compounded Medications Perrigo Export Regulations Pfizer Quality Control Contract Drugmakers Contract Development Amgen Specialty Pharmacy Regulatory Compliance Generic Drug Production WuXi AppTec Legal Defense Product Safety Company Warnings Eli Lilly and Co.

India Halts Aveo Pharmaceuticals Over Illegal Opioid Exports to West Africa

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Hurricane Helene Disrupts IV Fluid Supply, Delaying Surgeries Nationwide

Massive Cocaine Seizure in Gujarat Uncovers International Drug Network

Pioneers of Obesity Drugs Win Prestigious Lasker Award

FDA Faces Backlog of 2,000 Uninspected Drug Plants Post-COVID

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

Pharmacy Owner Pleads No Contest in Meningitis Outbreak Case

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition

Western Pharma Companies Pivot to India Amid China Concerns